131 related articles for article (PubMed ID: 26136482)
41. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
42. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years.
Andersson ML; Svensson B; Bergman S
J Rheumatol; 2013 Dec; 40(12):1977-85. PubMed ID: 24187108
[TBL] [Abstract][Full Text] [Related]
43. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
[TBL] [Abstract][Full Text] [Related]
44. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
[TBL] [Abstract][Full Text] [Related]
45. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
[TBL] [Abstract][Full Text] [Related]
46. Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study.
Urata Y; Uesato R; Tanaka D; Nakamura Y; Motomura S
Ann Rheum Dis; 2012 Apr; 71(4):534-40. PubMed ID: 22021897
[TBL] [Abstract][Full Text] [Related]
47. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
[TBL] [Abstract][Full Text] [Related]
48. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
49. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
Thiele K; Huscher D; Bischoff S; Späthling-Mestekemper S; Backhaus M; Aringer M; Kohlmann T; Zink A;
Ann Rheum Dis; 2013 Jul; 72(7):1194-9. PubMed ID: 22915625
[TBL] [Abstract][Full Text] [Related]
50. Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan.
Yamanaka H; Inoue E; Singh G; Tanaka E; Nakajima A; Taniguchi A; Hara M; Tomatsu T; Kamatani N
Mod Rheumatol; 2007; 17(4):283-9. PubMed ID: 17694260
[TBL] [Abstract][Full Text] [Related]
51. Toward Electronic Health Recording: Evaluation of Electronic Patient-reported Outcome Measures System for Remote Monitoring of Early Rheumatoid Arthritis.
El Miedany Y; El Gaafary M; Youssef S; Bahlas S; Almedany S; Ahmed I; Palmer D
J Rheumatol; 2016 Dec; 43(12):2106-2112. PubMed ID: 27633823
[TBL] [Abstract][Full Text] [Related]
52. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
[TBL] [Abstract][Full Text] [Related]
53. Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
Xie W; Li J; Zhang X; Li G; Hao Y; Zhao J; Wang L; Sun X; Fan Y; Zhang Z
Clin Exp Rheumatol; 2018; 36(5):820-828. PubMed ID: 29533754
[TBL] [Abstract][Full Text] [Related]
54. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account.
Huscher D; Sengler C; Gromnica-Ihle E; Bischoff S; Eidner T; Ochs W; Richter J; Zink A
Clin Exp Rheumatol; 2013; 31(2):256-62. PubMed ID: 23305590
[TBL] [Abstract][Full Text] [Related]
55. Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.
Bernelot Moens SJ; van der Valk FM; Strang AC; Kroon J; Smits LP; Kneepkens EL; Verberne HJ; van Buul JD; Nurmohamed MT; Stroes ES
Arthritis Res Ther; 2016 May; 18(1):115. PubMed ID: 27209093
[TBL] [Abstract][Full Text] [Related]
56. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Int J Rheum Dis; 2018 Nov; 21(11):1977-1985. PubMed ID: 27452347
[TBL] [Abstract][Full Text] [Related]
57. Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.
Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
Rheumatol Int; 2015 Nov; 35(11):1851-5. PubMed ID: 26238094
[TBL] [Abstract][Full Text] [Related]
58. Adjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan study.
Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
Reumatol Clin; 2016; 12(1):34-8. PubMed ID: 25869900
[TBL] [Abstract][Full Text] [Related]
59. Treatment delays for patients with new-onset rheumatoid arthritis presenting to an Australian early arthritis clinic.
Ison M; Duggan E; Mehdi A; Thomas R; Benham H
Intern Med J; 2018 Dec; 48(12):1498-1504. PubMed ID: 29808525
[TBL] [Abstract][Full Text] [Related]
60. Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea.
Song JJ; Song YW; Bae SC; Cha HS; Choe JY; Choi SJ; Kim HA; Kim J; Kim SS; Lee CK; Lee J; Lee SH; Lee SS; Lee SK; Lee SW; Park SH; Park W; Shim SC; Suh CH; Yoo B; Yoo DH; Yoo WH
J Korean Med Sci; 2018 Dec; 33(52):e346. PubMed ID: 30584418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
